The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ruffo Frank since 2016.
This trader's CIK number is 1654450.
At the time of last reporting, Ruffo Frank was the Chief Financial Officer of Aclaris Therapeutics, Inc.. (stock ticker symbol ACRS).
Also see all insider trading activities at Aclaris Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | ACRS | 0 | $0 | 12,823 | $199,333 | 46,222 | $0 |
| 2021 | ACRS | 0 | $0 | 102,376 | $2,658,117 | 71,111 | $0 |
| 2020 | ACRS | 0 | $0 | 0 | $0 | 64,113 | $0 |
| 2019 | ACRS | 0 | $0 | 0 | $0 | 6,425 | $0 |
| 2018 | ACRS | 2,500 | $43,512 | 0 | $0 | 7,750 | $0 |
| 2017 | ACRS | 0 | $0 | 0 | $0 | 2,550 | $0 |
| 2016 | ACRS | 0 | $0 | 0 | $0 | 1,250 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-10 | ACRS | Sale | 12,823 | 15.54 | 199,333 |
| 2022-03-01 | ACRS | Option Ex | 34,050 | .00 | 0 |
| 2022-03-02 | ACRS | Option Ex | 8,297 | .00 | 0 |
| 2022-02-01 | ACRS | Option Ex | 3,875 | .00 | 0 |
| 2021-06-02 | ACRS | Sale | 15,037 | 21.91 | 329,385 |
| 2021-06-01 | ACRS | Option Ex | 33,189 | .00 | 0 |
| 2021-04-26 | ACRS | Sale | 27,339 | 26.12 | 714,012 |
| 2021-04-23 | ACRS | Sale | 30,000 | 26.98 | 809,490 |
| 2021-04-22 | ACRS | Sale | 30,000 | 26.84 | 805,230 |
| 2021-03-02 | ACRS | Option Ex | 8,297 | .00 | 0 |
| 2021-03-01 | ACRS | Option Ex | 25,750 | .00 | 0 |
| 2021-02-01 | ACRS | Option Ex | 3,875 | .00 | 0 |
| 2020-12-15 | ACRS | Option Ex | 1,300 | .00 | 0 |
| 2020-06-01 | ACRS | Option Ex | 33,188 | .00 | 0 |
| 2020-03-02 | ACRS | Option Ex | 25,750 | .00 | 0 |
| 2020-02-03 | ACRS | Option Ex | 3,875 | .00 | 0 |
| 2019-12-18 | ACRS | Option Ex | 1,250 | .00 | 0 |
| 2019-12-16 | ACRS | Option Ex | 1,300 | .00 | 0 |
| 2019-02-01 | ACRS | Option Ex | 3,875 | .00 | 0 |
| 2018-12-18 | ACRS | Option Ex | 1,250 | .00 | 0 |
| 2018-12-15 | ACRS | Option Ex | 1,300 | .00 | 0 |
| 2018-05-07 | ACRS | Option Ex | 5,200 | .00 | 0 |
| 2018-05-07 | ACRS | Buy | 1,250 | 18.22 | 22,775 |
| 2018-04-06 | ACRS | Buy | 1,250 | 16.59 | 20,737 |
| 2017-12-18 | ACRS | Option Ex | 1,250 | .00 | 0 |
| 2017-12-15 | ACRS | Option Ex | 1,300 | .00 | 0 |
| 2016-12-18 | ACRS | Option Ex | 1,250 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ruffo Frank (Chief Financial Officer of Aclaris Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.